Previous 10 | Next 10 |
NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today...
Applied Therapeutics, Inc. ( APLT ) increased 34% to $35.18 on Wednesday after announcing positive topline results from the Phase 2 portion of its ACTION-Galactosemia study of AT-007 for adult Galactosemia patients. The data was so compelling according to the company that it plans to apply f...
Shares of Applied Therapeutics (NASDAQ: APLT) are up 29% at 12:38 p.m. EST after the biotech reported positive data from a phase 2 clinical trial of AT-007 in galactosemia patients. People with galactosemia can't properly process a sugar called galactose, which is found in food and also mad...
Gainers: ShiftPixy (NASDAQ: PIXY ) +162% . More news on: ShiftPixy, Inc., Wah Fu Education Group Limited, Verastem, Inc., Stocks on the move, Read more ...
ShiftPixy (NASDAQ: PIXY ) +199% on completing recapitalization . More news on: ShiftPixy, Inc., Applied Therapeutics, Inc., Mechel PAO, Stocks on the move, Read more ...
Thinly traded micro cap Applied Therapeutics (NASDAQ: APLT ) is up 21% premarket on average volume in reaction to positive results from a Phase 2 clinical trial, ACTION-Galactosemia , evaluating candidate AT-007 in adult patients with galactosemia , a rare inherited metabol...
AT-007 demonstrated a robust and sustained reduction in galactitol vs placebo; significant plasma galactitol reduction of ~50% (p<0.01) AT-007 was well-tolerated; no drug-related adverse events reported at any dose to date Applied Therapeutics expects to file for regulatory appr...
Investing in IPO stocks can be fun, but also risky. There can be a scarcity of information about a brand new equity. And sometimes the underwriters intentionally lowball the value of a company, in order to hype the stock (and reward the bank's clients who bought shares on the cheap). None...
NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), announced today that Shoshana Shendelman, Ph.D., Founder, Chief Executive Officer and Chair of the Board, will ring the Nasdaq Closing Bell on Tuesday, December 17, 2019, at 4:00 p.m. ET. The ceremony wil...
NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the presentation of d...
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NYSE Market:
Applied Therapeutics Inc. Website:
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company was adde...
2024-06-11 10:45:04 ET Palo Alto Networks Inc (PANW) PANW is trading UP for the last 5 days, and it at trading at $313.28 with volume of 858,188 and a one day change of $4.23 (1.37%). Palo Alto Networks Inc has a 52-week low of 201.17 and a 52-week high of $380.84. The business's 50...